{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:37:15Z","timestamp":1790098635791,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK125372"],"award-info":[{"award-number":["R01DK125372"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY028169"],"award-info":[{"award-number":["R01EY028169"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jconrel.2022.12.012","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T12:30:39Z","timestamp":1671021039000},"page":"621-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38\/P53 signaling axis"],"prefix":"10.1016","volume":"353","author":[{"given":"Raghu","family":"Ganugula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil K.","family":"Nuthalapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianxiong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Friend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sheikh-Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.V. Ravi","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.12.012_bb0005","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jama.2015.9536","article-title":"Diabetes: advances in diagnosis and treatment","volume":"314","author":"Nathan","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrendo.2017.39","article-title":"Insulin analogues in type 1 diabetes mellitus: getting better all the time","volume":"13","author":"Mathieu","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0015","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"365","author":"Stumvoll","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0020","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41574-020-0392-2","article-title":"Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus","volume":"16","author":"Scheen","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0025","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142243","article-title":"Pharmacological treatment of hyperglycemia in type 2 diabetes","volume":"131","author":"Taylor","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fendo.2018.00532","article-title":"beta-cell failure or beta-cell abuse?","volume":"9","author":"Erion","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","article-title":"Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors","volume":"17","author":"DeFronzo","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s13300-017-0256-5","article-title":"Healthcare resource use, costs, and disease progression associated with diabetic nephropathy in adults with type 2 diabetes: a retrospective observational study","volume":"8","author":"Zhou","year":"2017","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113798","article-title":"Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy","volume":"21","author":"Rayego-Mateos","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0050","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/13543784.2018.1538352","article-title":"Targeting inflammation in diabetic nephropathy: a tale of hope","volume":"27","author":"Moreno","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0055","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2337\/db12-0046","article-title":"Intrarenal dopamine inhibits progression of diabetic nephropathy","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0060","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2337\/db13-1829","article-title":"Noninvasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized 13C dehydroascorbate magnetic resonance","volume":"64","author":"Keshari","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0065","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1523-1755.2001.060003858.x","article-title":"Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway","volume":"60","author":"Wilmer","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.toxrep.2014.12.017","article-title":"Curcumin protects rat liver from streptozotocin-induced diabetic pathophysiology by counteracting reactive oxygen species and inhibiting the activation of p53 and MAPKs mediated stress response pathways","volume":"2","author":"Ghosh","year":"2015","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0075","doi-asserted-by":"crossref","first-page":"7047238","DOI":"10.1155\/2016\/7047238","article-title":"Oxidative stress in diabetic nephropathy with early chronic kidney disease","volume":"2016","author":"Miranda-Diaz","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0080","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/MMBR.68.2.320-344.2004","article-title":"ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions","volume":"68","author":"Roux","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0085","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87877","article-title":"Systems biology analysis reveals role of MDM2 in diabetic nephropathy","volume":"1","author":"Saito","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/10715760801998646","article-title":"Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy","volume":"42","author":"Tikoo","year":"2008","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0095","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.2337\/db13-0305","article-title":"Transforming growth factor-beta-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy","volume":"62","author":"Deshpande","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2119\/molmed.2010.00002","article-title":"MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival","volume":"16","author":"Bhatt","year":"2010","journal-title":"Mol. Med."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1681\/ASN.2008111133","article-title":"Activation of p53 promotes renal injury in acute aristolochic acid nephropathy","volume":"21","author":"Zhou","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nm.2144","article-title":"Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury","volume":"16","author":"Yang","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0115","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2008111204","article-title":"siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury","volume":"20","author":"Molitoris","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cophys.2020.09.016","article-title":"The role of inflammation in hypertension: novel concepts","volume":"19","author":"Patrick","year":"2021","journal-title":"Curr. Opin. Physiol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0125","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0135","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-019-0213-9","article-title":"Targeting innate immune mediators in type 1 and type 2 diabetes","volume":"19","author":"Donath","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030781","article-title":"Mechanistic basis for the role of phytochemicals in inflammation-associated chronic diseases","volume":"27","author":"Cote","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0145","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2007.08.021","article-title":"Molecular understanding and modern application of traditional medicines: triumphs and trials","volume":"130","author":"Corson","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0150","doi-asserted-by":"crossref","first-page":"5401760","DOI":"10.1155\/2022\/5401760","article-title":"Protective effect and possible mechanisms of artemisinin and its derivatives for diabetic nephropathy: a systematic review and meta-analysis in animal models","volume":"2022","author":"Feng","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020639","article-title":"Curcumin and weight loss: does it work?","volume":"23","author":"Kasprzak-Drozd","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/j.jrn.2016.01.013","article-title":"The effect of dietary supplementation with curcumin on redox status and Nrf2 activation in patients with nondiabetic or diabetic proteinuric chronic kidney disease: a pilot study","volume":"26","author":"Jimenez-Osorio","year":"2016","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0165","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1186\/s13063-020-04923-w","volume":"21","author":"Karandish","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0170","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0035-1545345","article-title":"Curcumin attenuates urinary excretion of albumin in type II diabetic patients with enhancing nuclear factor erythroid-derived 2-like 2 (Nrf2) system and repressing inflammatory signaling efficacies","volume":"123","author":"Yang","year":"2015","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0175","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1002\/anie.201107724","article-title":"Curcumin\u2014from molecule to biological function","volume":"51","author":"Esatbeyoglu","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0180","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1039\/C8CC10021G","article-title":"Double-headed nanosystems for oral drug delivery","volume":"55","author":"Kaur","year":"2019","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0185","doi-asserted-by":"crossref","first-page":"eabb7878","DOI":"10.1126\/sciadv.abb7878","article-title":"Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation","volume":"6","author":"Ganugula","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078217","article-title":"Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model","volume":"8","author":"Grama","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0195","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/bph.13816","article-title":"Nano-curcumin safely prevents streptozotocin-induced inflammation and apoptosis in pancreatic beta cells for effective management of type 1 diabetes mellitus","volume":"174","author":"Ganugula","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.xkme.2019.07.006","article-title":"Continuous glucose monitoring and glycemic control in patients with type 2 diabetes mellitus and CKD","volume":"1","author":"Presswala","year":"2019","journal-title":"Kidney Med."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0205","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00125-013-3115-6","article-title":"Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-kappaB\/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis","volume":"57","author":"Yang","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0210","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.biocel.2013.02.009","article-title":"ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy","volume":"45","author":"Chen","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0215","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2010020143","article-title":"The NLRP3 inflammasome promotes renal inflammation and contributes to CKD","volume":"21","author":"Vilaysane","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0220","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2337\/dc09-2132","article-title":"Barriers to achieving glycemic targets: who omits insulin and why?","volume":"33","author":"Weinger","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0225","doi-asserted-by":"crossref","first-page":"F156","DOI":"10.1152\/ajprenal.00409.2012","article-title":"Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus","volume":"304","author":"Vallon","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0230","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0235","first-page":"577","article-title":"Kidney disease in diabetes mellitus: cross-linking between hyperglycemia, redox imbalance and inflammation","volume":"112","author":"Amorim","year":"2019","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.536213","article-title":"Acute hyperglycemia may induce renal tubular injury through mitophagy inhibition","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0245","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fcell.2020.00187","article-title":"Transforming growth factor-Beta1 in diabetic kidney disease","volume":"8","author":"Zhao","year":"2020","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0255","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1172\/JCI72271","article-title":"Molecular mechanisms of diabetic kidney disease","volume":"124","author":"Reidy","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0260","doi-asserted-by":"crossref","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","article-title":"Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets","volume":"312","author":"Pichler","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0265","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/labinvest.2014.163","article-title":"Serum amyloid a and inflammation in diabetic kidney disease and podocytes","volume":"95","author":"Anderberg","year":"2015","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0270","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.2014.271","article-title":"Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy","volume":"87","author":"Shahzad","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0275","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/ki.2014.322","article-title":"Revisiting inflammation in diabetic nephropathy: the role of the Nlrp3 inflammasome in glomerular resident cells","volume":"87","author":"Sakai","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","author":"Tuttle","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0285","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.intimp.2018.07.027","article-title":"Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-kappaB\/p38 signaling pathway in high-fat diet\/streptozotocin-induced diabetic mice","volume":"63","author":"Song","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0290","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ki.2014.226","article-title":"Hyperglycemia, p53, and mitochondrial pathway of apoptosis are involved in the susceptibility of diabetic models to ischemic acute kidney injury","volume":"87","author":"Peng","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173503","article-title":"Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: preclinical evidences with therapeutic approaches","volume":"885","author":"Ram","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0300","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1440-1797.2007.00796.x","article-title":"Rodent models of streptozotocin-induced diabetic nephropathy","volume":"12","author":"Tesch","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0305","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.mce.2012.10.024","article-title":"Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway","volume":"365","author":"Huang","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0310","article-title":"Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0315","series-title":"The Diabetic Kidney","first-page":"59","article-title":"Podocytes and diabetic nephropathy","author":"Jerums","year":"2006"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0320","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/0886022X.2015.1107823","article-title":"Evaluation of serum NGAL and hepcidin levels in chronic kidney disease patients","volume":"38","author":"Avci Cicek","year":"2016","journal-title":"Ren. Fail."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0325","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/pedi.13095","article-title":"AdDit, S.B.I.O.I. the, Biomarkers associated with early stages of kidney disease in adolescents with type 1 diabetes","volume":"21","author":"Marcovecchio","year":"2020","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0330","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/sj.bjp.0707666","article-title":"Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy","volume":"153","author":"Tikoo","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0335","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.nut.2008.12.007","article-title":"Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB","volume":"25","author":"Chiu","year":"2009","journal-title":"Nutrition"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0340","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.mehy.2012.12.041","article-title":"A novel mechanism of NALP3 inducing ischemia reperfusion injury by activating MAPK pathway in acute renal failure","volume":"80","author":"Hao","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jconrel.2022.12.012_bb0345","doi-asserted-by":"crossref","first-page":"F49","DOI":"10.1152\/ajprenal.00032.2009","article-title":"Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy","volume":"298","author":"Rane","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0350","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1530\/JOE-16-0324","article-title":"The role of the p53 tumor suppressor in metabolism and diabetes","volume":"231","author":"Kung","year":"2016","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0355","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.spinee.2019.07.013","article-title":"Effect of curcumin on the inflammatory reaction and functional recovery after spinal cord injury in a hyperglycemic rat model","volume":"19","author":"Lee","year":"2019","journal-title":"Spine J."},{"key":"10.1016\/j.jconrel.2022.12.012_bb0360","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2021.12531","article-title":"Screening for prediabetes and Type 2 Diabetes: US preventive services task force recommendation statement","volume":"326","author":"U.S.P.S.T. Force","year":"2021","journal-title":"JAMA"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:39:18Z","timestamp":1759163958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922008264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":72,"alternative-id":["S0168365922008264"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.012","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanocurcumin combined with insulin alleviates diabetic kidney disease through P38\/P53 signaling axis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}